Gujarat Kidney And Super Speciality Limited (NSE:GKSL)

India flag India · Delayed Price · Currency is INR
114.15
+1.27 (1.13%)
At close: Feb 12, 2026
Market Cap9.00B
Revenue (ttm)461.67M +5,773.4%
Net Income114.42M +11,519.2%
EPS2.13 +7,453.2%
Shares Out78.84M
PE Ratio53.71
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,309,250
Average Volume889,327
Open112.99
Previous Close112.88
Day's Range112.00 - 115.39
52-Week Range98.36 - 123.00
Betan/a
RSI68.65
Earnings DateFeb 14, 2026

About NSE:GKSL

Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy. It also offers Renal Surgery, Vascular Surgery, Gynecology and obstetrics, Robotic Surgery, Bariatric Surgery, Laparoscopic Surgery, Endocrine Surgery, Neurosurgery, and Joint Replacement services. Its facilities include intensive care unit, patient counselling, operation theatres, and dialysis center. Gujarat Kidney And Super Speciality Limit... [Read more]

Industry Hospitals
Founded 2014
Employees 338
Stock Exchange National Stock Exchange of India
Ticker Symbol GKSL
Full Company Profile

Financial Performance

In fiscal year 2025, NSE:GKSL's revenue was 402.42 million, an increase of 742.89% compared to the previous year's 47.74 million. Earnings were 94.13 million, an increase of 449.19%.

Financial Statements